AVA-201

N/A

Report date: 2023/04/02 18:56:04

Base Information

Drug NameAVA-201
Drug Alias NameAVA-201
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitorsRNA interferenceVascular endothelial growth factor inhibitors +[4] 
TargetsNuclear factor NF-kappa-B complexProto-oncogene proteins c-aktVascular endothelial growth factor
Therapy Area/IndicationsLeukoplakiaMouth Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAvalon Globocare Corp
China Registration ClassN/A

Develop Information

Active CompaniesAvalon Globocare Corp
Inactive CompaniesN/A
Active IndicationsLeukoplakiaMouth Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A